Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
viridi's Profile
Displaying 151-200 of 258 result(s).
CYDY CytoDyn Inc
10/20/2020 11:26:41 AM
The DSMC recommendations seem like (9)
CYDY CytoDyn Inc
10/20/2020 11:16:18 AM
Lying implies malicious intent. It (8)
CYDY CytoDyn Inc
10/16/2020 12:05:25 PM
My hunch says: Bad news gets a PR a (1)
CYDY CytoDyn Inc
10/16/2020 12:26:39 AM
“Quote: But the word “Potential (1)
CYDY CytoDyn Inc
10/16/2020 12:04:23 AM
“ including a potential regulator (2)
CYDY CytoDyn Inc
10/15/2020 11:57:39 PM
Well, alternatively, it could be th
CYDY CytoDyn Inc
10/14/2020 2:23:29 AM
I put more stock in Art Bell. (1)
CYDY CytoDyn Inc
10/14/2020 2:16:29 AM
“Or worse .... POTUS has not clu (1)
CYDY CytoDyn Inc
10/11/2020 12:54:16 PM
Technically you are mostly right, t (3)
CYDY CytoDyn Inc
10/08/2020 10:18:39 AM
I would hope the DSMC would be give (1)
CYDY CytoDyn Inc
10/08/2020 10:07:55 AM
“Great scenario TechGuru. I would (4)
CYDY CytoDyn Inc
10/07/2020 10:59:03 AM
“The EIND patients clearly show t (3)
CYDY CytoDyn Inc
10/06/2020 6:55:00 PM
“Dr Yo livestream today, CD12...
CYDY CytoDyn Inc
10/06/2020 2:44:04 PM
Dr. Yo noted that he thought if tru (3)
CYDY CytoDyn Inc
10/06/2020 1:23:20 AM
“It is too late.” Too late exis (4)
CYDY CytoDyn Inc
10/05/2020 9:50:52 PM
“1.3 million people die a year ar (7)
CYDY CytoDyn Inc
10/05/2020 6:53:11 PM
"Again, with due respect, I doubt y (14)
CYDY CytoDyn Inc
10/05/2020 6:07:41 PM
hmmm... you spend a lot of time her (8)
CYDY CytoDyn Inc
10/04/2020 7:17:29 PM
The study summary does not use the
CYDY CytoDyn Inc
10/04/2020 6:23:31 PM
The RECOVERY study reported 22.9% i (2)
CYDY CytoDyn Inc
10/04/2020 1:40:38 PM
There is a long history of presenti (1)
CYDY CytoDyn Inc
10/02/2020 5:38:26 PM
Politics and management complaints (2)
CYDY CytoDyn Inc
10/02/2020 12:42:13 PM
“the President took a trial of HC
CYDY CytoDyn Inc
09/30/2020 2:23:59 PM
Today was a buying opportunity and (2)
CYDY CytoDyn Inc
09/30/2020 1:53:52 PM
He said he doesn’t know which arm
CYDY CytoDyn Inc
09/21/2020 12:18:29 PM
There is no way one human has the t
CYDY CytoDyn Inc
09/17/2020 1:29:32 PM
As one of my mentors told me: if pe (3)
CYDY CytoDyn Inc
09/17/2020 11:49:12 AM
“After sleeping on it, I think th (2)
CYDY CytoDyn Inc
09/15/2020 3:08:11 PM
“ why bother spending that much t
CYDY CytoDyn Inc
09/15/2020 11:28:47 AM
The CD12 trial (with expected bette (1)
CYDY CytoDyn Inc
09/15/2020 1:18:53 AM
“Some potential competition? Just
CYDY CytoDyn Inc
09/13/2020 1:03:04 AM
If the post stays, by definition th (1)
CYDY CytoDyn Inc
09/13/2020 12:29:33 AM
That should be “closed the border
CYDY CytoDyn Inc
09/13/2020 12:24:44 AM
Reading through the thread of this (3)
CYDY CytoDyn Inc
09/09/2020 1:45:13 PM
Did anyone else get a phone call fr
CYDY CytoDyn Inc
09/08/2020 7:20:24 PM
Agree 100%. As the saying goes, it
CYDY CytoDyn Inc
09/08/2020 7:11:48 PM
Agreed - I don’t expect the trial
CYDY CytoDyn Inc
09/08/2020 6:55:25 PM
I saw that too. I am struck by some (4)
CYDY CytoDyn Inc
09/08/2020 6:36:51 PM
AstraZeneca vaccine put on hold due (2)
CYDY CytoDyn Inc
09/07/2020 1:45:41 PM
There is significant conjecture on (4)
CYDY CytoDyn Inc
09/06/2020 12:47:15 PM
I don’t either and predictions ar (1)
CYDY CytoDyn Inc
09/04/2020 1:57:40 AM
My recollection was that Dr Parviz (2)
CYDY CytoDyn Inc
09/03/2020 8:25:33 PM
Chessmaster, nice skewer on the Zer (1)
CYDY CytoDyn Inc
09/03/2020 10:48:11 AM
My concerns about a trial for long (1)
CYDY CytoDyn Inc
08/25/2020 11:58:46 AM
I hold our medical and scientific c (6)
CYDY CytoDyn Inc
08/25/2020 11:04:02 AM
The difference between lying and (7)
CYDY CytoDyn Inc
08/24/2020 11:01:07 PM
What I don’t understand is why th (1)
CYDY CytoDyn Inc
08/20/2020 6:04:36 PM
The concept of a dual or multi drug
CYDY CytoDyn Inc
08/17/2020 12:30:37 PM
Would it be insider info from Patte
CYDY CytoDyn Inc
08/17/2020 12:20:14 PM
CYDY Facebook poster is claiming NP
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Sound Group Finalizes Share Repurchase Program Successfully
  • Sagimet Biosciences Set to Showcase Fibrosis Findings at AASLD
  • Shoals Technologies Group, Inc. Upcoming Earnings Release
  • Ocular Therapeutix Innovation Highlighted at Scientific Conferences
  • Axsome Therapeutics Financial Update: Conference Call on Q3 2025
  • Insight into USA Rare Earth's Upcoming Financial Conference Call
  • Sono-Tek Corporation to Host Earnings Call on Financial Results
  • Akero Therapeutics Unveils Promising Efruxifermin Data for Liver Disease
  • Akero Therapeutics Showcases Efruxifermin Data at AASLD 2025
  • Aduro Clean Technologies Announces Conference Participation in 2025
  • Fractyl Health's Innovative Gene Therapy Shows Weight Loss Promise
  • Aduro Clean Technologies Debuts at Investment Conference
  • Anfield Energy's Velvet-Wood Mine Project Gains Momentum
  • Ocular Therapeutix Highlights Upcoming Scientific Engagements
  • Rekor Systems Partners with Georgia DOT for Major Contract
  • Caliber Properties Advances EV Charging Infrastructure Growth
  • Balchem Corporation to Host Q3 2025 Financial Results Call
  • Shoals Technologies Group Set for Q3 2025 Earnings Call
  • Sono-Tek Prepares for Earnings Call: Insights and Innovations
  • Sagimet Biosciences to Present Key Findings at AASLD 2025
  • GXO Strengthens Global Logistics Partnership with Dolce&Gabbana
  • Balchem Corporation Prepares for Q3 2025 Financial Review
  • Axsome Therapeutics Set to Share Q3 2025 Financial Insights
  • Zeta Network Group Partners with SOLV Foundation for Innovation
  • EnviroGold Secures Initial Funding to Propel Growth Strategy
  • Exploring Sustainable Farming with WSSA and NAICC's Insights
  • Exciting Q3 2025 Conference Call Details from Eldorado Gold
  • Jade Biosciences Secures $135 Million in Innovative Funding
  • Evergold Corp. Proposes Strategic Share Consolidation Plan
  • Kyndryl Unveils AI-Driven Aviation Cloud Solution for Airlines
  • NeoVolta Secures Strategic Acquisition Aiming for Growth Boost
  • Eldorado Gold Sets Exciting Q3 2025 Conference Call Event
  • NeoVolta's Strategic Move with Neubau Energy Enhances Battery Systems
  • Cognia's Innovative Accreditation Enhancements for Schools
  • Exploring the Future of Autoimmune Disease Treatment with JADE201
  • Market Experts Highlight Inflation Concerns and Dollar Risks
  • Children's Medical Center Dallas Achieves Top Pediatric Rankings
  • Tech Leaders Warn Against AI Overvaluation and Market Risks
  • Novavax Marks Major Progress with Sanofi, Tapping Milestone Funds
  • Trump's Infrastructure Initiative Sparks Mining Opportunity in Alaska
  • Elevate LLC Strengthens Market Position with Investment
  • Investing in Industrial Stocks: A Smart October Move
  • Peer AI Secures $12.1M to Revolutionize Drug Approval Processes
  • Cyngn's CEO Discusses Strategic Initiatives for Business Growth
  • McCormick & Company Delivers Strong Growth Amid Challenges
  • OppFi's Upcoming Q3 2025 Earnings Report and Insights
  • Alzheimer's Disease Diagnosis: A Call for Immediate Action
  • TORL BioTherapeutics Clinches $96M Financing for Cancer Therapy
  • Empowering Entrepreneurs: Prospera’s Success Stories Event
  • Ovii Unveils Tropical Flavor for Women's Health Support
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site